EquityFlow
›
Companies
› Asimov
Asimov
Y Combinator · Winter 2026
Biotech
· Boston, US ·
asimov.com
Synthetic biology design tools
Real-world human movement data for humanoid robots
Funding history
Date
Round
Amount
Jan 2023
Series B
Asimov, a US synthetic-biology startup, raised a USD175M Series B (USD200M total) led by CPP Investments.
$200M
Investors
Andreessen Horowitz
Canada Pension Plan Investment Board
Fidelity Management & Research Company
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →